Shufeng Zhou
- Molecular Biology top 5%
- Pharmacology top 0.1%
- Oncology top 5%
- Pharmacology top 1%
- Pediatrics, Perinatology and Child Health top 2%
- Topics
- Pharmacogenetics and Drug Metabolism (13 papers)Drug Transport and Resistance Mechanisms (8 papers)Cancer therapeutics and mechanisms (8 papers)
- Cited by
- PharmacologyBiochemistry
- Journals
- PLoS ONEDevelopmentCancer Research
In The Last Decade
Shufeng Zhou
110 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Molecular Biology 2.3k
- Pharmacology 1.2k
- Oncology 913
- Pharmacology 819
- Pediatrics, Perinatology and Child Health 449
Countries citing papers authored by Shufeng Zhou
This map shows the geographic impact of Shufeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufeng Zhou more than expected).
Fields of papers citing papers by Shufeng Zhou
This network shows the impact of papers produced by Shufeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufeng Zhou. The network helps show where Shufeng Zhou may publish in the future.
Co-authorship network of co-authors of Shufeng Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Shufeng Zhou. A scholar is included among the top collaborators of Shufeng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufeng Zhou. Shufeng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 19 | |
| 5 | 4 | |
| 6 | 152 | |
| 7 | Combination of immunotherapy with anaerobic bacteria for immunogene therapy of solid tumours | 17 |
| 8 | 33 | |
| 9 | 11 | |
| 10 | Influence of UGT1A9 intronic I399C4T polymorphism on SN-38 glucuronidation in Asian cancer patients | 2 |
| 11 | 9 | |
| 12 | 20 | |
| 13 | 69 | |
| 14 | 23 | |
| 15 | 87 | |
| 16 | 64 | |
| 17 | 48 | |
| 18 | 22 | |
| 19 | 46 | |
| 20 | 73 |
About Shufeng Zhou
Shufeng Zhou is a scholar working on Pharmacology, Complementary and alternative medicine and Molecular Biology, having authored 112 papers that have together received 5.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (8 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Pharmacology (1.2k citations), Pharmacology (819 citations) and Biochemistry (331 citations). Shufeng Zhou has collaborated with scholars based in China, Australia and Singapore. Frequent co-authors include Balram Chowbay, Junping Liu, Yihuai Gao, Eli Chan, Wei Duan, Min Huang, Xiaotian Li, Xihu Dai, Yong Li and Min Huang. Their work appears in journals such as PLoS ONE, Development and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.